A novel GLP-1 and FGF21 dual agonist has therapeutic potential for diabetes and non-alcoholic steatohepatitis
Pan, Qi, Lin, Shushan, Li, Yu, Liu, Liang, Li, Xiaoping, Gao, Xianglei, Yan, Jiangyu, Gu, Baohua, Chen, Xiaofeng, Li, Wenjia, Tang, Xinfa, Chen, Chao, Guo, Lixin
Published in EBioMedicine (01.01.2021)
Published in EBioMedicine (01.01.2021)
Get full text
Journal Article
A phase I study comparing the pharmacokinetics of the biosimilar (RD12014) with liraglutide (Victoza) in healthy Chinese male subjects
Zhou, Ruirui, Guo, Linfeng, Gao, Xianglei, Wang, Yijun, Xu, Wenjing, Zou, Yang, Li, Wenjia, Zhuang, Yulei, Liu, Gangyi, Liu, Yanmei
Published in Clinical and translational science (01.10.2022)
Published in Clinical and translational science (01.10.2022)
Get full text
Journal Article
A pharmacokinetic study comparing the biosimilar HEC14028 and Dulaglutide (Trulicity®) in healthy Chinese subjects
Gao, Xianglei, Di, Yujing, Lv, Yuan, Luan, Yingcai, Xiong, Yang, Xu, Yuli, Li, Yusheng, Guo, Linfeng, Li, Xiaoping, Deng, Li, Zhuang, Yulei, Hou, Jie
Published in Clinical and translational science (01.04.2024)
Published in Clinical and translational science (01.04.2024)
Get full text
Journal Article
A phase I study comparing the pharmacokinetics of the biosimilar in healthy Chinese male subjects
Zhou, Ruirui, Guo, Linfeng, Gao, Xianglei, Wang, Yijun, Xu, Wenjing, Zou, Yang, Li, Wenjia, Zhuang, Yulei, Liu, Gangyi, Liu, Yanmei
Published in Clinical and translational science (01.10.2022)
Published in Clinical and translational science (01.10.2022)
Get full text
Journal Article